UniQuest Pty Limited

The University of Queensland

Back to directory

Visualisation of cyclic peptides - cyclotides by Uniquest

UniQuest is the main commercialisation company of The University of Queensland. It specialises in global technology transfer and facilitates access for all business sectors to UQ's world class expertise, intellectual property and facilities. Since 1984, UniQuest has built, commercialised and managed an extensive intellectual property and asset portfolio, with more than 1,500 patents and 70 companies resulting from university-based discoveries and expertise. Since 2000, UniQuest and its start-ups have raised a $0.5B to take UQ technologies to market. UniQuest-licensed UQ innovations have generated net product sales of more than $13 billion since 2007. UniQuest was responsible for the commercialisation of the HPV vaccine Gardasil®, the Triple P Positive Parenting Program, the image correction technology used in two-thirds of the world's MRI machines and Spinifex Pty Ltd – a biopharmaceutical company acquired recently in one of Australia's largest ever biotech deals.

Website http://www.Uniquest.com.au

Key science sectors

Strengths and capabilities

  • Access to over 7,000 leading researchers
  • Expertise in therapeutics, personalised medicine and medical devices
  • Small molecule drug discovery and development
  • Collaborative R&D
  • Contract research
  • Licence and Option to Licence agreements
  • Start-up company creation

Facilities and major equipment

  • Queensland Emory Drug Development Initiative (QEDDI)
  • Ilab start-up incubator

Number of research staff

Upto 20 research staff


Level 7 General Purpose South Building, Staff House Road, The University of Queensland, St Lucia, 4067

Organisation type

  • Commercialisation company

Update details

Is this your centre? See any issues? Send a request to update your listing.

Register your centre

Register your centre to be listed in this directory.